Mitocholine Ltd
09051662
Healthy
No risk factors detected.
Details
Compliance
Last accounts
31/05/2025
unaudited abridged
Next accounts due
28/02/2027
Confirmation statement
Last: 26/01/2026
Due 09/02/2027
Industry
Officers
Persons with Significant Control
Former PSCs
Dr Larisa Andreeva
Ceased 23/06/2023
Igor Pomytkin
Ceased 05/07/2019
CompanyRankvs 281+ SIC 72110 peers77
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/05/2025
Net Worth
£655k
Balance sheet strength
Cash
£576k
Cash in the bank
Net Current Assets
£652k
Working capital
Current Assets
£805k
Current Liabilities
£153k
Fixed Assets
£2k
Debtors
£229k
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2025 | 5.27 | -£788k |
| 2024 | 13.03 | -£1.2M |
| 2023 | 101.20 | +£834k |
| 2022 | 11.41 | +£1.6M |
| 2021 | 4.54 | +£227k |
| 2020 | — | -£134k |
| 2019 | 0.01 | — |
Derived from filed accounts. Not audited figures.